1012 related articles for article (PubMed ID: 26838600)
1. Periodontitis induced by
Blasco-Baque V; Garidou L; Pomié C; Escoula Q; Loubieres P; Le Gall-David S; Lemaitre M; Nicolas S; Klopp P; Waget A; Azalbert V; Colom A; Bonnaure-Mallet M; Kemoun P; Serino M; Burcelin R
Gut; 2017 May; 66(5):872-885. PubMed ID: 26838600
[TBL] [Abstract][Full Text] [Related]
2. Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.
Branchereau M; Reichardt F; Loubieres P; Marck P; Waget A; Azalbert V; Colom A; Padmanabhan R; Iacovoni JS; Giry A; Tercé F; Heymes C; Burcelin R; Serino M; Blasco-Baque V
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1091-101. PubMed ID: 27033119
[TBL] [Abstract][Full Text] [Related]
3. Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice.
Li H; Yang H; Ding Y; Aprecio R; Zhang W; Wang Q; Li Y
J Periodontal Res; 2013 Oct; 48(5):582-90. PubMed ID: 23317150
[TBL] [Abstract][Full Text] [Related]
4. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
5. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X; LaRosa KB; Kawai T; Taubman MA
Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous vaccination with Porphyromonas gingivalis ameliorates periodontitis by modulating Th17/Treg imbalance in a murine model.
Wang L; Guan N; Jin Y; Lin X; Gao H
Int Immunopharmacol; 2015 Mar; 25(1):65-73. PubMed ID: 25604387
[TBL] [Abstract][Full Text] [Related]
7. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.
Hamamoto Y; Ouhara K; Munenaga S; Shoji M; Ozawa T; Hisatsune J; Kado I; Kajiya M; Matsuda S; Kawai T; Mizuno N; Fujita T; Hirata S; Tanimoto K; Nakayama K; Kishi H; Sugiyama E; Kurihara H
Arthritis Res Ther; 2020 Oct; 22(1):249. PubMed ID: 33076980
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 signaling contributes to alveolar bone resorption in Porphyromonas gingivalis-induced periodontitis in mice.
Nagashima H; Shinoda M; Honda K; Kamio N; Hasuike A; Sugano N; Arai Y; Sato S; Iwata K
J Oral Sci; 2017 Dec; 59(4):571-577. PubMed ID: 29093284
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model.
Kashiwagi Y; Aburaya S; Sugiyama N; Narukawa Y; Sakamoto Y; Takahashi M; Uemura H; Yamashita R; Tominaga S; Hayashi S; Nozaki T; Yamada S; Izumi Y; Kashiwagi A; Bamba T; Ishihama Y; Murakami S
Sci Rep; 2021 Sep; 11(1):18398. PubMed ID: 34526589
[TBL] [Abstract][Full Text] [Related]
10. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
[TBL] [Abstract][Full Text] [Related]
11. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis.
Marchesan JT; Morelli T; Lundy SK; Jiao Y; Lim S; Inohara N; Nunez G; Fox DA; Giannobile WV
Mol Oral Microbiol; 2012 Dec; 27(6):483-95. PubMed ID: 23134613
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
[TBL] [Abstract][Full Text] [Related]
13. High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens.
Blasco-Baque V; Serino M; Vergnes JN; Riant E; Loubieres P; Arnal JF; Gourdy P; Sixou M; Burcelin R; Kemoun P
PLoS One; 2012; 7(11):e48220. PubMed ID: 23133617
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice.
de Molon RS; Mascarenhas VI; de Avila ED; Finoti LS; Toffoli GB; Spolidorio DM; Scarel-Caminaga RM; Tetradis S; Cirelli JA
Clin Oral Investig; 2016 Jul; 20(6):1203-16. PubMed ID: 26411857
[TBL] [Abstract][Full Text] [Related]
15. Natural killer T cells mediate alveolar bone resorption and a systemic inflammatory response in response to oral infection of mice with Porphyromonas gingivalis.
Aoki-Nonaka Y; Nakajima T; Miyauchi S; Miyazawa H; Yamada H; Domon H; Tabeta K; Yamazaki K
J Periodontal Res; 2014 Feb; 49(1):69-76. PubMed ID: 23586756
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tamibarotene on innate immune response in the model of Porphyromonas gingivalis induced periodontitis].
Jin Y; Liu D; Fang X; Gao K; Lin X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Mar; 50(3):146-50. PubMed ID: 26081852
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota.
Watanabe K; Katagiri S; Takahashi H; Sasaki N; Maekawa S; Komazaki R; Hatasa M; Kitajima Y; Maruyama Y; Shiba T; Komatsu K; Ohsugi Y; Tanaka K; Matsuzawa A; Hirota T; Tohara H; Eguchi Y; Anzai K; Hattori A; Iwata T
FASEB J; 2021 Feb; 35(2):e21171. PubMed ID: 33197074
[TBL] [Abstract][Full Text] [Related]
18. The oral microbiome and the immunobiology of periodontal disease and caries.
Costalonga M; Herzberg MC
Immunol Lett; 2014 Dec; 162(2 Pt A):22-38. PubMed ID: 25447398
[TBL] [Abstract][Full Text] [Related]
19. Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis.
Sandal I; Karydis A; Luo J; Prislovsky A; Whittington KB; Rosloniec EF; Dong C; Novack DV; Mydel P; Zheng SG; Radic MZ; Brand DD
Arthritis Res Ther; 2016 Oct; 18(1):249. PubMed ID: 27784339
[TBL] [Abstract][Full Text] [Related]
20. TLR2 promoter hypermethylation creates innate immune dysbiosis.
Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
